XML 72 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Merger with Mirna Therapeutics - Additional Information (Detail)
$ in Millions
Aug. 28, 2017
USD ($)
Director
shares
Dec. 31, 2018
shares
Dec. 31, 2017
shares
Business Acquisition [Line Items]      
Merger completion date Aug. 28, 2017    
Number of members on Board of Directors | Director 7    
Exchange ratio of common stock 0.5532    
Common stock outstanding | shares   25,401,479 16,272,617
Synlogic      
Business Acquisition [Line Items]      
Number of members on Board of Directors | Director 5    
Mirna therapeutics      
Business Acquisition [Line Items]      
Common stock outstanding | shares 20,900,000    
Market capitalization | $ $ 35.0    
Fair value, net asset (Liability) | $ $ 42.6    
Mirna therapeutics | Common Stock | Synlogic      
Business Acquisition [Line Items]      
Share ownership following merger, percent 83.00%